Double Medical Technology Co., Ltd. (002901)
SZSE
38.70
-1.13 (-2.84%)
Closed
Sep 11, 2026
Day's Range
38.5139.88
52 wk Range
38.5159.99
Financial Statements - 002901 - Double Medical Technology Co., Ltd.
Revenue
2.60B▲ 21.8%
Net Income
636.87M▲ 65.3%Net Margin 24.5%
EBITDA
889.82M▲ 46.8%
Free Cash Flow
697.83M▲ 306.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 2.60B | 2.13B | 1.53B | 1.43B | 1.99B | 1.58B |
| Cost of Goods | 767.18M | 667.25M | 492.23M | 333.91M | 311.05M | 224.23M |
| Gross Profit | 1.83B | 1.46B | 1.04B | 1.10B | 1.68B | 1.36B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 719.06M | 448.81M | 113.61M | 115.96M | 817.99M | 708.72M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 730.04M | 428.41M | 99.74M | 147.45M | 802.51M | 709.63M |
| Income Tax | 93.16M | 43.12M | 13.40M | 37.89M | 111.01M | 94.87M |
| Net Income | 636.87M | 385.29M | 86.33M | 109.56M | 691.50M | 614.75M |
| EPS Basic | 1.47 | 0.86 | 0.14 | 0.22 | 1.68 | 1.51 |
| EPS Diluted | 1.47 | 0.86 | 0.14 | 0.22 | 1.67 | 1.51 |
| Basic Shares Outstanding | 407.91M | 414.88M | 421.23M | 420.70M | 400.77M | 401.11M |
| Diluted Shares Outstanding | 407.91M | 414.88M | 421.23M | 420.70M | 400.77M | 401.11M |
| Ebit | 736.22M | 434.90M | 106.89M | 150.55M | 803.06M | 708.72M |
| Ebitda | 889.82M | 606.33M | 262.10M | 256.01M | 897.91M | 771.37M |
| Net Income Continuous Operations | 636.87M | 385.29M | 86.33M | 109.56M | 691.50M | 614.75M |
| Minority Interests | -37.24M | -28.48M | -27.36M | -17.01M | -18.19M | -9.07M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
